362 related articles for article (PubMed ID: 16387571)
1. Cardiovascular issues in hypogonadism and testosterone therapy.
Shabsigh R; Katz M; Yan G; Makhsida N
Am J Cardiol; 2005 Dec; 96(12B):67M-72M. PubMed ID: 16387571
[TBL] [Abstract][Full Text] [Related]
2. Effect of testosterone replacement on whole body glucose utilisation and other cardiovascular risk factors in males with idiopathic hypogonadotrophic hypogonadism.
Tripathy D; Shah P; Lakshmy R; Reddy KS
Horm Metab Res; 1998 Oct; 30(10):642-5. PubMed ID: 9851674
[TBL] [Abstract][Full Text] [Related]
3. The dark side of testosterone deficiency: III. Cardiovascular disease.
Traish AM; Saad F; Feeley RJ; Guay A
J Androl; 2009; 30(5):477-94. PubMed ID: 19342698
[TBL] [Abstract][Full Text] [Related]
4. Hypogonadism and metabolic syndrome: implications for testosterone therapy.
Makhsida N; Shah J; Yan G; Fisch H; Shabsigh R
J Urol; 2005 Sep; 174(3):827-34. PubMed ID: 16093964
[TBL] [Abstract][Full Text] [Related]
5. The dark side of testosterone deficiency: I. Metabolic syndrome and erectile dysfunction.
Traish AM; Guay A; Feeley R; Saad F
J Androl; 2009; 30(1):10-22. PubMed ID: 18641413
[TBL] [Abstract][Full Text] [Related]
6. Cardiovascular effect of testosterone replacement therapy in aging male.
Francomano D; Bruzziches R; Natali M; Aversa A; Spera G
Acta Biomed; 2010; 81 Suppl 1():101-6. PubMed ID: 20518199
[TBL] [Abstract][Full Text] [Related]
7. Clomiphene increases free testosterone levels in men with both secondary hypogonadism and erectile dysfunction: who does and does not benefit?
Guay AT; Jacobson J; Perez JB; Hodge MB; Velasquez E
Int J Impot Res; 2003 Jun; 15(3):156-65. PubMed ID: 12904801
[TBL] [Abstract][Full Text] [Related]
8. Testosterone and ageing: what have we learned since the Institute of Medicine report and what lies ahead?
Miner MM; Seftel AD
Int J Clin Pract; 2007 Apr; 61(4):622-32. PubMed ID: 17343664
[TBL] [Abstract][Full Text] [Related]
9. The effect of androgens on lipids.
Monroe AK; Dobs AS
Curr Opin Endocrinol Diabetes Obes; 2013 Apr; 20(2):132-9. PubMed ID: 23422242
[TBL] [Abstract][Full Text] [Related]
10. Does testosterone have a role in erectile function?
Mikhail N
Am J Med; 2006 May; 119(5):373-82. PubMed ID: 16651047
[TBL] [Abstract][Full Text] [Related]
11. Testosterone therapy for postmenopausal women: efficacy and safety.
Somboonporn W
Semin Reprod Med; 2006 Apr; 24(2):115-24. PubMed ID: 16633985
[TBL] [Abstract][Full Text] [Related]
12. [Efficacy and safety of hormonal therapy with androgens (androgel) in men with erectile dysfunction, partial androgen deficiency of aging male and cardiovascular diseases].
Kalinchenko SIu; Vorslov LO; Aglamazian NL; Morgunov LIu
Urologiia; 2007; (1):57, 59-61. PubMed ID: 17472002
[TBL] [Abstract][Full Text] [Related]
13. Testosterone replacement therapy in male hypogonadism is not associated with increase of endothelin-1 levels.
Kumanov P; Tomova A; Kirilov G
Int J Androl; 2007 Feb; 30(1):41-7. PubMed ID: 16879620
[TBL] [Abstract][Full Text] [Related]
14. Prostate-specific antigen changes and prostate cancer in hypogonadal men treated with testosterone replacement therapy.
Coward RM; Simhan J; Carson CC
BJU Int; 2009 May; 103(9):1179-83. PubMed ID: 19154450
[TBL] [Abstract][Full Text] [Related]
15. Insulin resistance, the insulin resistance syndrome, and cardiovascular disease.
Reaven GM
Panminerva Med; 2005 Dec; 47(4):201-10. PubMed ID: 16489319
[TBL] [Abstract][Full Text] [Related]
16. [Testosterone and atherosclerosis in males during andropause].
Medraś M; Jankowska E
Pol Merkur Lekarski; 1999 Apr; 6(34):205-7. PubMed ID: 10391062
[TBL] [Abstract][Full Text] [Related]
17. The association between fibrate use, change in high-density lipoprotein cholesterol, and the risk of cardiovascular disease: a retrospective chart review involving up to 8 years of follow-up.
Nichols GA; Koro CE; Chan W; Bowlin SJ; Sprecher DL
Clin Ther; 2006 Feb; 28(2):243-50. PubMed ID: 16678645
[TBL] [Abstract][Full Text] [Related]
18. Baseline data from the TRiUS registry: symptoms and comorbidities of testosterone deficiency.
Miner MM; Khera M; Bhattacharya RK; Blick G; Kushner H
Postgrad Med; 2011 May; 123(3):17-27. PubMed ID: 21566412
[TBL] [Abstract][Full Text] [Related]
19. Cardiovascular Disease, Hypogonadism and Erectile Dysfunction: Early Detection, Prevention and the Positive Effects of Long-Term Testosterone Treatment: Prospective Observational, Real-Life Data.
Alwani M; Yassin A; Talib R; Al-Qudimat A; Aboumarzouk O; Al-Zoubi RM; Saad F; Haider KS; Al Ansari A
Vasc Health Risk Manag; 2021; 17():497-508. PubMed ID: 34465997
[TBL] [Abstract][Full Text] [Related]
20. Hypogonadism, ED, metabolic syndrome and obesity: a pathological link supporting cardiovascular diseases.
Corona G; Mannucci E; Forti G; Maggi M
Int J Androl; 2009 Dec; 32(6):587-98. PubMed ID: 19226407
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
